Daldrup-Link Heike E, Simon Gerhard H, Brasch Robert C
Department of Radiology, UCSF Medical Center, San Francisco, CA 94143, USA.
Curr Pharm Des. 2006;12(21):2661-72. doi: 10.2174/138161206777698774.
Tumor angiogenesis imaging should provide non-invasive assays of tumor vascular characteristics to supplement the now conventional diagnostic imaging goals of depicting tumor location, size, and morphology. This article will review the current status of angiogenesis imaging approaches, considering ultrasound, CT, MR, SPECT, PET and optical techniques with attention to their respective capabilities and limitations. As a group, these imaging methods have some potential to depict and quantify tumor microvascular features, including those considered to be functionally associated with tumor angiogenesis. Additionally, new molecule-specific imaging techniques may serve to depict those biochemical pathways and regulatory events that control blood vessel growth and proliferation. Non-invasive monitoring of anti-angiogenic therapies has great appeal and should find wide application for defining tumor microvascular and metabolic changes, because treatment-related changes in tumor morphology tend to occur rather late and are non-specific. Future developments are likely to include "fusion" or "hybrid" imaging methods. Superimposed data from MR imaging with spectroscopy, PET with CT, and PET with MR should be able to integrate advantages of different modalities yielding comprehensive information about tumor structure, function and microenvironment.
肿瘤血管生成成像应提供肿瘤血管特征的非侵入性检测方法,以补充目前传统诊断成像描绘肿瘤位置、大小和形态的目标。本文将综述血管生成成像方法的现状,涉及超声、CT、MR、SPECT、PET和光学技术,并关注它们各自的能力和局限性。作为一个整体,这些成像方法有一定潜力描绘和量化肿瘤微血管特征,包括那些被认为与肿瘤血管生成功能相关的特征。此外,新的分子特异性成像技术可能有助于描绘控制血管生长和增殖的生化途径及调节事件。抗血管生成治疗的非侵入性监测具有很大吸引力,在定义肿瘤微血管和代谢变化方面应能得到广泛应用,因为与治疗相关的肿瘤形态变化往往出现较晚且不具有特异性。未来的发展可能包括“融合”或“混合”成像方法。将磁共振成像与光谱学、PET与CT以及PET与MR的叠加数据应该能够整合不同模态的优势,从而提供有关肿瘤结构、功能和微环境的全面信息。